Open AccessDirect-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis
Author(s) -
Kamolyut Lapumnuaypol,
David Pisarcik,
Prapaipan Putthapiban,
Weera Sukhumthammarat,
Karn Wijarnpreecha,
Charat Thongprayoon,
Patompong Ungprasert
Publication year - 2020
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/ijmr.ijmr_1088_18
Subject(s) - medicine , meta analysis , hepatitis c virus , confidence interval , hepatitis c , cohort study , cohort , diabetes mellitus , type 2 diabetes mellitus , adverse effect , type 2 diabetes , virus , immunology , endocrinology
Several epidemiologic studies have demonstrated that type 2 diabetes mellitus (T2DM) is more prevalent in patients infected with hepatitis C virus (HCV), and the eradication of HCV has been shown to decrease the risk of T2DM. This meta-analysis was undertaken to see if treatment with direct-acting antiviral (DAA) agents would improve glycaemic control among HCV-infected patients with T2DM.